Marco
Grrrrrrr!
- Messages
- 2,386
- Location
- Near Cognac, France
Hi Bob
In my own naive way I thought this approach might give GSK the toolkit to hit retroviruses at source.
My understanding, which is probably wrong, is that retoviruses are RNA and need to 'write themselves' into cellular DNA to replicate. I also assumed that antiretroviral drugs prevent or slow replication but you are stuck with the retroviral infection for life.
Directly interfering with the RNA could kill XMRV off?
In theory?
Like this :
http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6WXR-4CHRYD6-2&_user=10&_coverDate=07%2F20%2F2004&_rdoc=1&_fmt=high&_orig=search&_sort=d&_docanchor=&view=c&_searchStrId=1278656559&_rerunOrigin=google&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=032bdcbbe337a743b0f3fdd9dbd33af4
In my own naive way I thought this approach might give GSK the toolkit to hit retroviruses at source.
My understanding, which is probably wrong, is that retoviruses are RNA and need to 'write themselves' into cellular DNA to replicate. I also assumed that antiretroviral drugs prevent or slow replication but you are stuck with the retroviral infection for life.
Directly interfering with the RNA could kill XMRV off?
In theory?
Like this :
http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6WXR-4CHRYD6-2&_user=10&_coverDate=07%2F20%2F2004&_rdoc=1&_fmt=high&_orig=search&_sort=d&_docanchor=&view=c&_searchStrId=1278656559&_rerunOrigin=google&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=032bdcbbe337a743b0f3fdd9dbd33af4